Abstract
Colorectal cancer being a life style disease, number of cases is increasing day by day. Oral drug delivery to treat colonic diseases encounters many problems like drug stability in the harsh environment of the upper GI tract, low percentage of drug remained in the dosage form to be released in the colon, heavy dilution of the drug released in the colon fluid etc. Hence novel strategies for colon targeting has attracted significant attention during the past 20 years in providing several therapeutic advantages particularly for drugs that are sensitive to acidic condition and to intestinal enzymes. Sustained colonic release of drugs can be useful in the treatment of nocturnal asthma, angina and arthritis while site specific release strategy is needed for local action for conditions involving colonic pathologies, such as ulcerative colitis, colorectal cancer, Crohn's disease and colon cancer. This article is focused on different polymeric materials particularly of natural origin that are considered to design different types of colon delivery systems and their comparative efficacies are discussed.
Keywords: Colon cancer, colon targeting, colon delivery of drugs, natural polymers.
Drug Delivery Letters
Title:Polymeric Drug Delivery Approaches for Colon Targeting: A Review
Volume: 4 Issue: 1
Author(s): Apninder Kaur, Amarjeet Kaur, Vishav P. Kaur, Manpreet Kaur and Ramchandra S. Murthy
Affiliation:
Keywords: Colon cancer, colon targeting, colon delivery of drugs, natural polymers.
Abstract: Colorectal cancer being a life style disease, number of cases is increasing day by day. Oral drug delivery to treat colonic diseases encounters many problems like drug stability in the harsh environment of the upper GI tract, low percentage of drug remained in the dosage form to be released in the colon, heavy dilution of the drug released in the colon fluid etc. Hence novel strategies for colon targeting has attracted significant attention during the past 20 years in providing several therapeutic advantages particularly for drugs that are sensitive to acidic condition and to intestinal enzymes. Sustained colonic release of drugs can be useful in the treatment of nocturnal asthma, angina and arthritis while site specific release strategy is needed for local action for conditions involving colonic pathologies, such as ulcerative colitis, colorectal cancer, Crohn's disease and colon cancer. This article is focused on different polymeric materials particularly of natural origin that are considered to design different types of colon delivery systems and their comparative efficacies are discussed.
Export Options
About this article
Cite this article as:
Kaur Apninder, Kaur Amarjeet, P. Kaur Vishav, Kaur Manpreet and S. Murthy Ramchandra, Polymeric Drug Delivery Approaches for Colon Targeting: A Review, Drug Delivery Letters 2014; 4 (1) . https://dx.doi.org/10.2174/22103031113036660017
DOI https://dx.doi.org/10.2174/22103031113036660017 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacokinetics/Pharmacodynamics Model-Supported Early Drug Development
Current Pharmaceutical Biotechnology Carbonic Anhydrase Related Protein VIII and its Role in Neurodegeneration and Cancer
Current Pharmaceutical Design The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer
Current Gene Therapy Dendritic Cells and their Receptors in Antitumor Immune Response
Current Molecular Medicine MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials
Current Molecular Pharmacology Nutraceuticals for Protection and Healing of Gastrointestinal Mucosa
Current Medicinal Chemistry Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Current Medicinal Chemistry - Anti-Cancer Agents Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry Pharmaceutical Interventions for Frailty and Sarcopenia
Current Pharmaceutical Design Characterization of Probiotic Lactobacillus plantarum MYS14 Isolated from Sannas, a Traditional Fermented Food for its Therapeutic Potential
Current Nutrition & Food Science Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer
Current Molecular Medicine Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
Current Cancer Drug Targets Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Current Cancer Therapy Reviews Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer
Current Cancer Drug Targets Recent Advances in the Chemistry and Biology of Folypoly-γ-glutamate Synthetase Substrates and Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Current Cancer Drug Targets The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell
Current Pharmaceutical Biotechnology LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets Strategies to Overcome Multi-Drug Resistance in Cancer Cells: the Contribution of siRNA and Nanotechnologies
Current Organic Chemistry Pharmacogenetics of the Human MDR1 Multidrug Transporter
Current Pharmacogenomics